Discuss the Market Trends
On each of the three show days we will host a free to attend, on-site content programme. For 2019, the programme is focused on three key themes; innovation, regional insights and government to industry initiatives. The below draft agenda provides an outline of discussion topics. Please note, this is a draft and therefore subject to change.
We are extending invitations to high-level speakers from government institutions, regulatory bodies, local pharma companies, MNC’s, distributors, research institutes, academia and innovators to discuss market insights, challenges, pportunities, policy, regulation and innovation across the entire Middle East & Africa region.
If you are interested in getting involved in the programme via a speaking or moderating role, please get in touch with Tara Dougal, our Head of Content.
2019 Conferences' Highlights
Creating Regulatory Harmony across the Middle East & North Africa
Moderator: Firas Nabulsi, Business Development Director, Aspen Health
Panellists: Dr. Hakkı Gürsöz, President, T.C. Ministry of Health - Turkish Medicines and Medical Devices Agency & Jeffrey Kemprecos, Head of Communications & Government Affairs, GSK Gulf
Spotlight on Oncology
Moderator: Manel Chikh, CEO, Zaphyr Pharmaceuticals
Panellists: Sawsan Al Madhi, Director General, Friends of Cancer Patients & Tamer Ali, Commercial Head Saudi Arabia and Oncology Practice Lead, IQVIA
East Africa: A Focus on the Fastest Growing Manufacturing Base
Moderator: Kayode Afolabi, DFS Africa
Panellist: Mutasaaga Joseph, Manager Business Development, Uganda National Drug Authority
CPhI MEA Africa Deal Room in collaboration with DFS Africa
Date – Tuesday 17 September, 2019
Venue – ADNEC, Abu Dhabi, UAE
Time – 10am – 4pm
The ‘Africa Deal Room’ connects Impact Investors, Private Equity Funds, Investment companies and Development Finance Institutions (DFIs) to vetted, relevant and development-focused high growth businesses in Africa. The event holding at CPhI MEA is focused of Pharmaceuticals and companies operating in the Pharma value chain. It offers the opportunity for both investors and businesses to ‘cut through the clutter’ in finding relevant and strategic partners to work with
Interested in Sponsorship Opportunities?